Trexquant Investment LP X Biotech Inc. Transaction History

Trexquant Investment LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$3.03 - $3.79 $27,239 - $34,072	-8,990 Reduced 40.91%	12,985 $45,000
Q3 2022 Nov 14, 2022	SELL	$3.58 - $5.88 $32,198 - $52,884	-8,994 Reduced 29.04%	21,975 $80,000
Q2 2022 Aug 11, 2022	BUY	$5.13 - $9.2 $72,173 - $129,434	14,069 Added 83.25%	30,969 $174,000
Q1 2022 May 13, 2022	SELL	$8.64 - $11.71 $32,382 - $43,889	-3,748 Reduced 18.15%	16,900 $146,000
Q4 2021 Feb 14, 2022	BUY	$10.95 - $16.07 $226,095 - $331,813	20,648 New	20,648 $230,000
Q1 2020 May 08, 2020	SELL	$8.89 - $24.94 $128,309 - $359,959	-14,433 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$8.33 - $19.95 $120,226 - $287,938	14,433 New	14,433 $269,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $118M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.